Saizen
Company: Ares-Serono
Approval Status: Approved May 1996
Treatment for: growth hormone deficiency, Turner Syndrome
Areas: Endocrinology; Musculoskeletal
General Information
Other Useful Resources
Saizen has been approved as a treatment for growth hormone deficiency in children. It is also prescribed for the treatment of Turner syndrome, a rare genetic disease, which solely affects girls.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
